Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
1.620
+0.040 (2.53%)
At close: Oct 20, 2025, 4:00 PM EDT
1.610
-0.010 (-0.59%)
After-hours: Oct 20, 2025, 7:59 PM EDT
Aptevo Therapeutics Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $11,100 → $5,920 | Strong Buy | Maintains | $11,100 → $5,920 | +365,332.10% | Sep 23, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $2,246,640 → $651,200 | Buy | Maintains | $2,246,640 → $651,200 | +40,197,430.86% | May 13, 2022 |
| Roth Capital | Roth Capital | Strong Buy Maintains $2,083,840 → $1,628,000 | Strong Buy | Maintains | $2,083,840 → $1,628,000 | +100,493,727.16% | May 28, 2021 |
| Piper Sandler | Piper Sandler | Buy Maintains $1,041,920 → $2,246,640 | Buy | Maintains | $1,041,920 → $2,246,640 | +138,681,381.48% | Nov 11, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates $5,470,080 | Strong Buy | Initiates | $5,470,080 | +337,659,159.26% | Apr 11, 2018 |
| Piper Sandler | Piper Sandler | Buy Initiates $3,190,880 | Buy | Initiates | $3,190,880 | +196,967,801.23% | Sep 9, 2016 |